Skip to main content
Bellicum Pharmaceuticals, Inc.Portfolio

Bellicum Pharmaceuticals, Inc.: Bellicum Announces Data Presentation at ASH 2018 Demonstrating Low Rates of Cancer Recurrence in Pediatric AML and ALL Patients Treated with Rivo-cel

By December 2, 2018March 9th, 2021No Comments